{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:09:26Z","timestamp":1790179766527,"version":"4.1.0"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.2967\/jnumed.118.220715","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T13:44:26Z","timestamp":1542807866000},"page":"910-916","source":"Crossref","is-referenced-by-count":42,"title":["Phase I Study of CTT1057, an <sup>18<\/sup>F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer"],"prefix":"10.2967","volume":"60","author":[{"given":"Spencer C.","family":"Behr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"VanBrocklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Blecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Jivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry P.","family":"Simko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kurhanewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Noworolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romelyn","family":"De Los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao G.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Langton-Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford E.","family":"Berkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"2021051712133027000_60.7.910.1","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ejrad.2014.06.028","article-title":"Limited evidence for the use of imaging to detect prostate cancer: a systematic review","volume":"83","author":"Blomqvist","year":"2014","journal-title":"Eur J Radiol."},{"key":"2021051712133027000_60.7.910.2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1148\/radiology.162.2.3797645","article-title":"Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging","volume":"162","author":"Hricak","year":"1987","journal-title":"Radiology."},{"key":"2021051712133027000_60.7.910.3","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.213.2.r99nv23473"},{"key":"2021051712133027000_60.7.910.4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-5347(17)38666-4","article-title":"The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations","volume":"142","author":"Shinohara","year":"1989","journal-title":"J Urol."},{"key":"2021051712133027000_60.7.910.5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.prnil.2017.02.003","article-title":"68Ga-prostate-specific membrane antigen-positron emission tomography\/computed tomography in advanced prostate cancer: current state and future trends","volume":"5","author":"Udovicich","year":"2017","journal-title":"Prostate Int."},{"key":"2021051712133027000_60.7.910.6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13014-017-0902-0","article-title":"Detection level and pattern of positive lesions using PSMA PET\/CT for staging prior to radiation therapy","volume":"12","author":"Schmidt-Hegemann","year":"2017","journal-title":"Radiat Oncol."},{"key":"2021051712133027000_60.7.910.7","first-page":"S13","article-title":"Overview of prostate-specific membrane antigen","volume":"6","author":"Chang","year":"2004","journal-title":"Rev Urol."},{"key":"2021051712133027000_60.7.910.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2021051712133027000_60.7.910.9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712133027000_60.7.910.10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.nucmedbio.2015.06.003","article-title":"A high-affinity [18F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer","volume":"42","author":"Ganguly","year":"2015","journal-title":"Nucl Med Biol."},{"key":"2021051712133027000_60.7.910.11","first-page":"1","article-title":"Fully automated preparation of [18F]CTT1057, a new prostate cancer imaging agent, prepared using the ORA Neptis\u00ae Perform Synthesizer","volume":"60","author":"Jivan","year":"2017","journal-title":"J Labelled Comp Radiopharm."},{"key":"2021051712133027000_60.7.910.12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00261-015-0590-x","article-title":"Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation","volume":"41","author":"Starobinets","year":"2016","journal-title":"Abdom Radiol (NY)."},{"key":"2021051712133027000_60.7.910.13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/ph7070779","article-title":"Novel preclinical and radiopharmaceutical aspects of [68Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer","volume":"7","author":"Eder","year":"2014","journal-title":"Pharmaceuticals (Basel)."},{"key":"2021051712133027000_60.7.910.14","doi-asserted-by":"crossref","unstructured":"Zacho HD Nielsen JB Haberkorn U Stenholt L Petersen LJ . 68Ga-PSMA PET\/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature. Clin Physiol Funct Imaging. October 29, 2017 [Epub ahead of print].","DOI":"10.1111\/cpf.12480"},{"key":"2021051712133027000_60.7.910.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2525-5"},{"key":"2021051712133027000_60.7.910.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.156133"},{"key":"2021051712133027000_60.7.910.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191395"},{"key":"2021051712133027000_60.7.910.18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol."},{"key":"2021051712133027000_60.7.910.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3419-0"},{"key":"2021051712133027000_60.7.910.20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","article-title":"(68)Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712133027000_60.7.910.21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2018172232","article-title":"Gallium 68 PSMA-11 PET\/MR imaging in patients with intermediate- or high-risk prostate cancer","volume":"288","author":"Park","year":"2018","journal-title":"Radiology."},{"key":"2021051712133027000_60.7.910.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3389-2"},{"key":"2021051712133027000_60.7.910.23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0768"},{"key":"2021051712133027000_60.7.910.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2298-2"},{"key":"2021051712133027000_60.7.910.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.104661"},{"key":"2021051712133027000_60.7.910.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160382"},{"key":"2021051712133027000_60.7.910.27","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.7150\/thno.18719","article-title":"177Lu-labeled phosphoramidate-based PSMA inhibitors: the effect of an albumin binder on biodistribution and therapeutic efficacy in prostate tumor-bearing mice","volume":"7","author":"Choy","year":"2017","journal-title":"Theranostics."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.220715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:39:16Z","timestamp":1621283956000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.220715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.2967\/jnumed.118.220715"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.220715","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]}}}